Source: BioPortfolio

Acucela: Acucela Meets with NASA and TRISH for Phase 1 Update for SSOCT Project

Acucela Inc. Acucela a clinicalstage ophthalmology company and whollyowned subsidiary of Kubota Pharmaceutical Holdings Co. Ltd. Tokyo 4596 announced today that the company was invited to meet with NASA and the Translational Research Institute for Space He...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Ryo Kubota's photo - Chairman & CEO of Acucela

Chairman & CEO

Ryo Kubota

CEO Approval Rating

85/100

Read more